Alejandro Gómez-Pinillos

Suggest Changes
Learn More
156 Background: Aberrant expression and function of the androgen receptor (AR) is determinant of CRPC progression. We previously demonstrated that the histone-deacetylase inhibitor panobinostat (PAN)(More)
  • 1